Terms: = Breast cancer AND PCSK7, Q16549, 9159, ENSG00000160613, PC8, SPC7, PC7, LPC AND Treatment
14 results:
1. Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer.
Tan Z; Deme P; Boyapati K; Claes BSR; Duivenvoorden AAM; Heeren RMA; Tressler CM; Haughey NJ; Glunde K
Breast Cancer Res; 2023 Nov; 25(1):148. PubMed ID: 38017485
[TBL] [Abstract] [Full Text] [Related]
2. Tafazzin mediates tamoxifen resistance by regulating cellular phospholipid composition in ER-positive breast cancer.
Li X; Zhang Y; Zhang T; Zhao L; Lin CG; Hu H; Zheng H
Cancer Gene Ther; 2024 Jan; 31(1):69-81. PubMed ID: 37935981
[TBL] [Abstract] [Full Text] [Related]
3. Engineering Lipusu with lysophosphatidylcholine for improved tumor cellular uptake and anticancer efficacy.
Li L; Zhan Q; Yi K; Chen N; Li X; Yang S; Hou X; Zhao J; Yuan X; Kang C
J Mater Chem B; 2022 Mar; 10(11):1833-1842. PubMed ID: 35212350
[TBL] [Abstract] [Full Text] [Related]
4. Adaptive Lumpectomy Boost Planning Can Reduce Normal Tissue Exposure in Patients Receiving Hypofractionated Whole breast Irradiation.
Sayan M; Yehia ZA; Jan I; Gupta A; Vergalasova I; Reviello M; Kumar S; Haffty B; Ohri N
Anticancer Res; 2022 Jan; 42(1):53-57. PubMed ID: 34969708
[TBL] [Abstract] [Full Text] [Related]
5. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for treatment of breast cancer.
Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
[TBL] [Abstract] [Full Text] [Related]
6. A Novel Strategy for Targeted Lipidomics Based on LC-Tandem-MS Parameters Prediction, Quantification, and Multiple Statistical Data Mining: Evaluation of Lysophosphatidylcholines as Potential cancer Biomarkers.
Zhang Q; Xu H; Liu R; Gao P; Yang X; Jin W; Zhang Y; Bi K; Li Q
Anal Chem; 2019 Mar; 91(5):3389-3396. PubMed ID: 30689358
[TBL] [Abstract] [Full Text] [Related]
7. Dosimetric effects of the kV based image-guided radiation therapy of prone breast external beam radiation: Towards the optimized imaging frequency.
Xu H; Lee SW; Guerrero M; Yi BY; Chen S; Becker SJ; Chung H; Cheston SB
J Appl Clin Med Phys; 2019 Jan; 20(1):212-219. PubMed ID: 30550644
[TBL] [Abstract] [Full Text] [Related]
8. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract] [Full Text] [Related]
9. Combined Laser Photocoagulation and anti-VEGF Injection treatment in Radiation Retinopathy.
Hurtikova K; Gerding H
Klin Monbl Augenheilkd; 2017 Apr; 234(4):515-519. PubMed ID: 28282695
[No Abstract] [Full Text] [Related]
10. The role and therapeutic potential of the autotaxin-lysophosphatidate signalling axis in breast cancer.
Teo K; Brunton VG
Biochem J; 2014 Oct; 463(1):157-65. PubMed ID: 25195735
[TBL] [Abstract] [Full Text] [Related]
11. [The efficacy of polychromatic visible and infrared radiation used for the postoperative immunological rehabilitation of patients with breast cancer].
zhevago NA; Samoĭlova KA; Davydova NI; Bychkova NV; Glazanova TV; Chubukina ZhV; Buĭniakova AI; Zimin AA
Vopr Kurortol Fizioter Lech Fiz Kult; 2012; (4):23-32. PubMed ID: 22994061
[TBL] [Abstract] [Full Text] [Related]
12. Comparative analysis of the post-lumpectomy target volume versus the use of pre-lumpectomy tumor volume for early-stage breast cancer: implications for the future.
Nichols EM; Dhople AA; Mohiuddin MM; Flannery TW; Yu CX; Regine WF
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):197-202. PubMed ID: 20394853
[TBL] [Abstract] [Full Text] [Related]
13. Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis.
Samadi N; Gaetano C; Goping IS; Brindley DN
Oncogene; 2009 Feb; 28(7):1028-39. PubMed ID: 19079345
[TBL] [Abstract] [Full Text] [Related]
14. BCAR1 expression in prostate cancer: association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining.
Fromont G; Vallancien G; Validire P; Levillain P; Cussenot O
Prostate; 2007 Feb; 67(3):268-73. PubMed ID: 17192874
[TBL] [Abstract] [Full Text] [Related]
